StockData
Pharming Group N.V. logo

Pharming Group N.V. (PHAR) stock

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30
$12.06−0.53 (-4.21%)

Close on Nov 17, 2026Market cap $846.23MP/E 301.5Yield –

Pharming operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was $25.84M. The highest annual figure on record is $76.26M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$25.84M–
FY2024Dec 31, 2024-$8.62M–
FY2023Dec 31, 2023-$5.39M-129.5%
FY2022Dec 31, 2022$18.23M+34.5%
FY2021Dec 31, 2021$13.56M-82.2%
FY2020Dec 31, 2020$76.26M+11.7%
FY2019Dec 31, 2019$68.25M–

More Pharming figures

See a number that looks wrong?